The largest database of trusted experimental protocols

Anti sars cov 2 spike elisa

Manufactured by EUROIMMUN
Sourced in Germany

The Anti-SARS-CoV-2 Spike ELISA is a laboratory equipment product developed by EUROIMMUN. It is an enzyme-linked immunosorbent assay (ELISA) used for the qualitative detection of antibodies against the spike protein of SARS-CoV-2, the virus that causes COVID-19.

Automatically generated - may contain errors

4 protocols using anti sars cov 2 spike elisa

1

Saliva-Based SARS-CoV-2 Antibody Evaluation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Saliva samples were collected aspirating with a sterile syringe, after removing the needle, from the oral cavity of all enrolled HCWs. Of note, saliva was collected 2-3 h after the last meal and/or drinking. All saliva samples were stored at −20°C until the time of testing. A semiquantitative determination of human IgA antibodies against the SARS-CoV-2 was performed on saliva samples, adapting the Anti-SARS-CoV-2 Spike ELISA (EUROIMMUN), according to the manufacturer’s instructions. Values were then normalized for comparison with a calibrator. Results were evaluated by calculating the ratio between the extinction of samples and the extinction of the calibrator. Results are reported as the ratio between OD samples and OD calibrator.
+ Open protocol
+ Expand
2

SARS-CoV-2 Spike Protein IgG ELISA

Check if the same lab product or an alternative is used in the 5 most similar protocols
A semi-quantitative in vitro determination of human IgG antibodies against the SARS-CoV-2 (S1) was performed on serum samples by using the anti-SARS-CoV-2 spike ELISA (EUROIMMUN, Lübeck, Germany), according to the manufacturer’s instructions. Values were then normalized by comparison with a calibrator. Results were obtained by calculating the ratio between the extinction of samples and the extinction of the calibrator. Results are reported as the ratio between the optical density (OD) from the sample and the OD from the calibrator. The ratio interpretation was as follows: negative, <0.8; borderline, ≥0.8 to <1.1; positive, ≥1.1.
+ Open protocol
+ Expand
3

SARS-CoV-2 Antibody Detection by ELISA

Check if the same lab product or an alternative is used in the 5 most similar protocols
A semi-quantitative in vitro determination of human IgG and IgA antibodies against the SARS-CoV-2 was performed on serum samples by using the Anti-SARS-CoV-2 Spike ELISA (EUROIMMUN), according to the manufacturer’s instructions. Values were then normalized for comparison with a calibrator. Results were evaluated by calculating the ratio between the extinction of samples and the extinction of the calibrator. Results are reported as the ratio between OD sample and OD calibrator. The ratio interpretation was as follows: < 0.8 = negative, ≥ 0.8 to < 1.1 = borderline, ≥ 1.1 = positive. To detect IgM anti-RBD we developed an in-house ELISA [17 (link)]. 96-well plates (Corning) were coated for 1 h at 37 °C with 1 μg/mL of purified SARS-CoV-2 RBD protein (Sino Biological). After washing with PBS 1 × /0.05% Tween and blocking with PBS 1 × /1% BSA, plates were incubated for 1 h at 37 °C with diluted sera (1:100). After washing again, plates were incubated for 1 h at 37 °C with peroxidase-conjugated goat anti-human IgM antibody (Jacksons ImmunoResearch Laboratories). The assay was developed with o-phenylenediamine tablets (Sigma-Aldrich) as a chromogen substrate. Absorbance at 450 nm was measured, and IgM concentrations were calculated by interpolation from the standard curve based on serial dilutions of monoclonal human IgM antibody against SARS-CoV-2 Spike-RBD (Invivogen).
+ Open protocol
+ Expand
4

SARS-CoV-2 IgG and IgA Antibody ELISA

Check if the same lab product or an alternative is used in the 5 most similar protocols
A semi-quantitative in vitro determination of human IgG antibodies against the SARS-CoV-2 (IgG S1) and of human IgA antibodies against the SARS-CoV-2 (IgA S1) was performed on serum samples by using the Anti-SARS-CoV-2 Spike ELISA (EUROIMMUN), according to the manufacturer’s instructions. Values were then normalized for comparison with a calibrator. Results were evaluated by calculating the ratio between the extinction of samples and the extinction of the calibrator. Results are reported as the ratio between OD sample and OD calibrator. The ratio interpretation was as follows: <0.8 = negative, ≥0.8 to <1.1 = borderline, ≥1.1 = positive.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!